Oxford University Press

JNCI Cancer Spectrum Template

Write in a clean editor, then format for JNCI Cancer Spectrum in one click — DocuGuru applies the official Oxford University Press template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.

About the JNCI Cancer Spectrum format

JNCI Cancer Spectrum is a peer-reviewed journal published by Oxford University Press, covering Global Cancer Incidence and Screening, Cancer survivorship and care, Cancer Risks and Factors.

PublisherOxford University Press
Reference styleAuthor–year (OUP)
Author–year — (Smith, 2023) in the text
Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', JNCI Cancer Spectrum, 12(3), pp. 45–58.

Formats any DOI in the closest standard style — JNCI Cancer Spectrum has no published style definition, so this is an approximation. No sign-up.

Publishes research inGlobal Cancer Incidence and Screening Cancer survivorship and care Cancer Risks and Factors Economic and Financial Impacts of Cancer Childhood Cancer Survivors' Quality of Life
ISSN2515-5091
Citation impact (2-yr)3.27
h-index54
i10-index403
Total citations16,171
Article processing charge$1,236
Open accessYes
Top institutions publishing hereNational Cancer Institute
Journal websiteacademic.oup.com
You getA submission-ready PDF and the editable LaTeX source — ready to submit.

Papers published in JNCI Cancer Spectrum per year

1
2006
1
2008
1
2011
9
2017
84
2018
106
2019
121
2020
104
2021
89
2022
109
2023
131
2024
123
2025

Citation impact of JNCI Cancer Spectrum by publication year

0
2006
15
2008
0
2011
107
2017
2.7K
2018
4.4K
2019
2.9K
2020
2.1K
2021
1K
2022
1.7K
2023
790
2024
214
2025

Citations each year’s papers have accumulated so far — the most recent years are still building up.

Most-cited papers in JNCI Cancer Spectrum

Using ChatGPT to evaluate cancer myths and misconceptions: artificial intelligence and cancer information

Skyler B. Johnson, Andy J. King, Echo L. Warner et al. · 1 Mar 2023

Data about the quality of cancer information that chatbots and other artificial intelligence systems provide are limited. Here, we evaluate the accuracy of cancer information on ChatGPT compared with the National Cancer Institute's (NCI's) answers by using the questions on the "Common Cancer Myths and Misconceptions" web page. The NCI's answers and ChatGPT answers to…

Impact of the COVID-19 Pandemic on Patient-Reported Outcomes of Breast Cancer Patients and Survivors

Claudia A. Bargon, Marilot C. T. Batenburg, Lilianne E. van Stam et al. · 25 Oct 2020

Abstract Background The coronavirus disease 2019 (COVID-19) pandemic (officially declared on the March 11, 2020), and the resulting measures, are impacting daily life and medical management of breast cancer patients and survivors. We evaluated to what extent these changes have affected quality of life, physical, and psychosocial well-being of patients previously or currently being treated…

Artificial intelligence chatbots will revolutionize how cancer patients access information: ChatGPT represents a paradigm-shift

Ashley M. Hopkins, Jessica M. Logan, Ganessan Kichenadasse et al. · 21 Feb 2023

On November 30, 2022, OpenAI enabled public access to ChatGPT, a next-generation artificial intelligence with a highly sophisticated ability to write, solve coding issues, and answer questions. This communication draws attention to the prospect that ChatGPT and its successors will become important virtual assistants to patients and health-care providers. In our assessments, ranging from answering…

An Anatomical Site and Genetic-Based Prognostic Model for Patients With Nuclear Protein in Testis (NUT) Midline Carcinoma: Analysis of 124 Patients

Nicole G. Chau, Clement Ma, Kristina Danga et al. · 1 Nov 2019

Abstract Background NUT midline carcinoma, renamed NUT carcinoma (NC), is an aggressive squamous cancer defined by rearrangement of the NUTM1 gene. Although a subset of patients can be cured, for the majority of patients the prognosis is grim. We sought to classify patients into risk groups based on molecular and clinicopathologic factors at the time…

Burden of Human Papillomavirus (HPV)-Related Cancers Attributable to HPVs 6/11/16/18/31/33/45/52 and 58

Silvia de Sanjosé, Beatriz Serrano, Sara Tous et al. · 31 Jul 2018

Abstract Background Many countries, mainly high- and upper-middle income, have implemented human papillomavirus (HPV) vaccination programs, with 47 million women receiving the full course of vaccine (three doses) in 2014. To evaluate the potential impact of HPV vaccines in the reduction of HPV-related disease, we aimed to estimate the HPV type distribution and burden of…

JNCI Cancer Spectrum template — frequently asked questions

How do I write a paper in the JNCI Cancer Spectrum format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the JNCI Cancer Spectrum template. When you export, DocuGuru compiles the paper into the official Oxford University Press format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does JNCI Cancer Spectrum use?
JNCI Cancer Spectrum uses Author–year (OUP) references, shown as author–year markers such as (Smith, 2023) in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', JNCI Cancer Spectrum, 12(3), pp. 45–58.
Do I need to know LaTeX to submit to JNCI Cancer Spectrum?
No. DocuGuru generates the oup-authoring-template LaTeX class and compiles the PDF for you in the background, so you get a Oxford University Press-ready JNCI Cancer Spectrum document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the JNCI Cancer Spectrum template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the JNCI Cancer Spectrum format with correct headings, figures, tables, and author–year citations.
Who publishes JNCI Cancer Spectrum?
JNCI Cancer Spectrum is a multidisciplinary journal published by Oxford University Press. DocuGuru's JNCI Cancer Spectrum template matches Oxford University Press's official submission format.
Can I export a submission-ready JNCI Cancer Spectrum PDF?
Yes — DocuGuru produces a PDF built with the official JNCI Cancer Spectrum template (the oup-authoring-template class) that is ready to submit to Oxford University Press, together with the matching LaTeX source files.
How much does the JNCI Cancer Spectrum template cost?
You can start writing in the JNCI Cancer Spectrum template for free. Exporting the final submission-ready JNCI Cancer Spectrum PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.
Use the JNCI Cancer Spectrum template